← SynDRA
SAR405
SynDRA canonical compound SYN1614431 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PIK3C3 |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PIK3C3 INHIBITOR
- PI3K inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HDAC1
- HDAC3
- HDAC2
- HDAC4
- HDAC5
- HDAC6
- HDAC8
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- RefChem:181308
- SAR 405
- MFCD28411361
- C19H21ClF3N5O2
- Racemic SAR405
- rac-SAR405
- GTPL9353
- orb1309129
- SCHEMBL16736080
- SCHEMBL29379330
- SAR405?
- SPDQRCUBFSRAFI-DOMZBBRYSA-N
- GLXC-05770
- GLXC-06914
- EX-A2522
- YKC40639
- BDBM50121212
- AKOS025396180
- CCG-269168
- CS-5756
- EBC-520132
- T12831L
- NCGC00381477-06
- NCGC00381477-07
- NCGC00388558-01
- AC-33652
- AS-75187
- DA-57659
- HY-12481
- SAR-405; SAR 405; SAR405
- P14670
- F866443
- 1TT
- (8S)-9-[(5-chloropyridin-3-yl)methyl]-2-[(3R)-3-methylmorpholin-4-yl]-8-(trifluoromethyl)-7,8-dihydro-6H-pyrimido[1,2-a]pyrimidin-4-one
Look up SAR405 in the interactive SynDRA portal →